The guardian of the genome

Slides:



Advertisements
Similar presentations
P53 The Master Guardian of the Genome. p53 gene mutations in human tumors Greenblatt et al. (1995) Cancer Res. 54: %
Advertisements

Genetics and Health Jennifer Eyvindson Epi 6181 November 2006.
A signal transducer and cancer Neurofibromin, ras, and cancer - utah.
IDENTIFICATION OF THE MOLECULAR MECHANISMS IN RETT SYNDROME AND RELATED DISORDERS (RTT-GENET) X.
Fbw7/hCdc4/Ago and Endometrial Cancer Ashmita Chatterjee Biology 169 April 4, 2006.
SMAD4/DPC4: A Tumor Suppressor James Brooks March 23 rd, 2006.
P53 gene mutations in human tumors Greenblatt et al. (1995) Cancer Res. 54: %
P53 The Master Guardian. R point Cell cycle control involves several checkpoints and checkpoint (molecular breaking) mechanisms.
Von Hippel-Lindau Syndrome (VHL) Presented by Kelley Montoya March 20, 2003.
Cancer and the Cell Cycle
MDM2: Oncogene Chan Lee. Discovery of MDM2: starting with tumor suppressor p53.
BRCA2 Blue: Rad51; Green: BRCA2
von Hippel-Lindau Syndrome (VHL)
P73 Shatil Amin March 27 th Content I.Structure and Function II.Regulation III.Is it involved in human cancers?
P53 gene mutations in human tumors Greenblatt et al. (1995) Cancer Res. 54: %
Tim Lockney. What is p57?  Alias: CDKN1C  316 Amino Acids long  Localized in the Nucleus  Important during development  Localized to Chromosome 11p15.5.
BRCA1 The First Breast Cancer Gene Presentation By Liz Mosley.
Malignant Melanoma and CDKN2A
REGULATION OF GENE EXPRESSION Chapter 18. Gene expression A gene that is expressed is “turned on”. It is actively making a product (protein or RNA). Gene.
Group Number: 2 Britney Porter, Sandra Nguyen, Eduardo Vargas and Samender Singh Randhawa.
1. p53 Structure, Function and Therapeutic Applications Provider: Dr.Davood Nourabadi(PhD,medical physiology) mdphysiology.persianblog.ir.
Pavel Yarmolenko Biology 169, Spring 2005 The von Hippel-Lindau (VHL) Tumor Suppressor Gene Inactivation and Its Involvement in Tumorgenesis.
P53 Missense Mutation Cancer. Outline Disease related to p53 Role and regulation pathway Structure of p53 Missense mutation and consequences Experiment’s.
BRCA2: Breast Cancer Susceptibility Gene 2 Lindy Behrend March 4, 2003.
Tumor Suppressor Gene Involved in Breast and Ovarian Cancers SCIENCE96/gene.cgi?BRCA1.
TSC1/Hamartin and Facial Angiofibromas Biology 169 Ann Hau.
MLH1: Hereditary non- polyposis colon cancer (HNPCC) By: Alison Edge.
BLOOM HELICASE (and BLOOM SYNDROME)
Cancer. Cancer is a disease of the cell cycle Caused by one or more of the following: Increase in growth signals Loss of inhibitory signals In addition,
Tumor-suppressor genes Tumor-suppressor genes, function like brakes, keep cell numbers down, either by inhibiting progress through.
New players in the BRCA1-dependent
Cell Cycle Checkpoints The Guardian Mechanisms of
Susceptibility to Inheritance
REGULATION OF GENE EXPRESSION
P14/19ARF as Tumor Suppressor
Kate Bradford BIOL 445 March 5, 2009
Mouse Double Minute 2 (MDM2)
Control of Gene Expression
p53 and Apoptosis: Master Guardian and Executioner
Structural features of the p53 gene and its encoded protein
P53 Tumor Supressor Protein
The Role of SMAD4 (DPC4) in Cancer
breast cancer 2, early onsetpro What does this protein make up or do?
Patient VB Li-Fraumeni Syndrome.
Immunogenetics Lecture 3: TcR.
von Hippel-Lindau Disease
What does this protein make up or do?
PTEN (a.k.a. MMAC1 and TEP1) and Cowden’s Disease
DNA Replication and Protein Synthesis Vocabulary Review Game
Extracellular Regulation of Apoptosis
P57Kip2 and Beckwith-Wiedemann Syndrome
BIOLOGY 12 Cancer.
PTEN Tumor Suppressor Extraordinaire
Figure 2 Oestrogen receptor signalling pathways
Nat. Rev. Urol. doi: /nrurol
Bloom Helicase & Bloom Syndrome
ARF and p16: One Locus, Two Tumor Suppressors
PTEN Tumor Suppressor and Cancer
Ataxia telangiectasia and the Role of ATM
Zea mays Viviparous 1 (vp1) Gene
M.B.Ch.B, MSC, PhD, DCH (UK), MRCPCH
Splitting p63 The American Journal of Human Genetics
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
Keeping p53 in Check: A High-Stakes Balancing Act
Specific Tumor Suppressor Genes
Canonical gliomagenesis mediators EGFR, P53, and retinoblastoma protein (RB1) are important for cancer signaling. Canonical gliomagenesis mediators EGFR,
Nat. Rev. Neurol. doi: /nrneurol
Tenets of PTEN Tumor Suppression
Figure 2 Mechanisms of RET activation in cancer
Presentation transcript:

The guardian of the genome p53 The guardian of the genome By Siddhartha Ray

p53: general info 393 amino acids long Localized to the nucleus Found at locus 17p13.1 About 200 germline TP53 mutations have been discovered One of a highly conserved gene family that also includes p63 and p73 However the other genes lack p53’s tumor suppressor abilities http://ghr.nlm.nih.gov/gene=tp53

Greenblatt et al. (1995) Cancer Res. 54:4855 Occurrence of p53 mutations in human cancers 50% Greenblatt et al. (1995) Cancer Res. 54:4855

Li-Fraumeni Syndrome (LFS) Rare autosomal dominant predisposition to certain types of cancer LFS has only been diagnosed in about 300 families wordwide It has been estimated that roughly half of LFS cases involve a p53 mutation Courtesy of Dr. Bob Duronio

p53 structure The p53 gene has 3 functional domains: http://www.kcl.ac.uk/kis/schools/life_sciences/life_sci/nikolovaR.html The p53 gene has 3 functional domains: N-terminal: contains transcription activation signal C-terminal: controls oligomerization Central area (aa 100-300): DNA binding site, contains transcription activation signal Most commonly mutated area in cancer is this central DNA-binding area

p53 binds DNA as a tetramer, upstream of target genes Unbound p53 p53 bound to DNA http://www.rcsb.org/pdb/molecules/pdb31_1.html

There are 3 methods of activating the p53 pathway and 3 potential results Guimaraes et Hainut (2002) Biochimie 84:83

Protein interactions in the p53 pathway Guimaraes et Hainut (2002) Biochimie 84:83

p53 is involved in a mutual feedback system with its E3 ubiquitin ligase mdm2 http://www.rockefeller.edu/pubinfo/p53part2.html Courtesy of Dr. Bob Duronio

p53-mediated cell cycle arrest versus apoptosis http://www.hcoa.org/newsite/FacultyandStaff/xiangwei_wu.asp

p53 knockout mouse p53 knockout mice were bred in 1992 by Donehower et al.

P53/mdm2 double knockout Bred in 1995 by Jones et. al p53 -/- mdm2-/- Courtesy of Dr. Bob Duronio

3 types of mutations Guimaraes et Hainut (2002) Biochimie 84:83

Late vs early acting mutations Guimaraes et Hainut (2002) Biochimie 84:83